RESUMEN
Several clinical trials have proved the efficacy and safety of T-cells chimeric antigen receptor (CAR-T cells) in treatment of malignant lymphoma and the first products were registered in the European Union in 2018. The shelf-life of CAR-T cell products in the liquid state is short, so cryopreservation offers a significant benefit for logistics in manufacturing and patient management. Direct shipment of the cryopreserved CAR-T cell therapy products to the clinical department is feasible, nevertheless, intermediate storage in the hospital cryostorage facility gives significant advantage in planning of their administration to patients. Moreover, some manufacturers prefer transport of the starting material cryopreserved at the collection site. The cryopreservation protocol used for starting material by the authors is based on combining dimethyl sulphoxide (DMSO) with hydroxyethyl starch (HES) and slow controlled cooling in cryobags housed in metal cassettes. This achieves the mononuclear cell post-thaw viability of 98.8 ± 0.5 % and recovery of 72.8, ± 10.2 %. Transport of the starting material to the manufactures and return transport of the CAR-T therapy product is performed by authorized courier companies. Intermediate cryostorage of the final CAR-T cell therapy product is performed in a separate dry-storage liquid nitrogen container. On the day of infusion, the cryopreserved products are transported to the clinical department in a dry shipper. On the wards the product is removed from the cassette, inserted into a sterile plastic bag, thawed in a 37 degree C water bath followed by immediate intravenous administration. The authors discuss the adherence of the used technology to good manufacturing practice (GMP) principles and genetic safety assurance rules. Doi: 10.54680/fr23310110112.
Asunto(s)
Receptores Quiméricos de Antígenos , Humanos , Receptores Quiméricos de Antígenos/genética , Criopreservación/métodos , Inmunoterapia Adoptiva/métodos , FríoRESUMEN
Human face is a dynamic system where facial expressions can rapidly modify geometry of facial features. Facial expressions are believed to be universal across world populations, but only a few studies have explored whether grimacing is sexually dimorphic and if so to what extent. The present paper explores inter- and intra-individual variation of human facial expressions with respect to individual's sex based on a set of neutral and expression-varying 3D facial scans. The study sample composed of 20 individuals (10 males and 10 females) for whom 120 scans featuring grimaces associated with disgust, surprise, "u" sound, smile and wide smile were collected by an optical scanner Vectra XT. In order to quantify the dissimilarity among 3D images, surface comparison approach based on aligned 3D meshes and closest point-to-point distances was carried out in Fidentis Analyst application. The study revealed that sexual dimorphism was indeed one of the factors which determined the extent and characteristics of facial deformations recorded for the studied expressions. In order to produce a grimace, males showed a tendency towards extending their facial movements while females were generally more restrained. Furthermore, the facial movements linked to the wide smile and "u" sound were revealed as the most extensive relative to the other expressions, while the smile and surprise were shown indistinguishable from the neutral face.
Asunto(s)
Expresión Facial , Caracteres Sexuales , Adulto , Análisis de Varianza , Cara/anatomía & histología , Femenino , Humanos , Imagenología Tridimensional , Masculino , Modelos Anatómicos , Sonrisa , Adulto JovenRESUMEN
The aim of the study was to identify the most important systemic and local risk factors for the development of infectious complications in patients with toxic epidermal necrolysis (TEN). MATERIAL AND METHODOLOGY: This is a multicentric study that included all patients with TEN who were hospitalized between 2000-2015 in specialized centres in the Czech Republic and Slovakia. The total catchment area included a population of over 12.5 million inhabitants. The actual implementation of the project was carried out using data obtained from the CELESTE (Central European LyEll Syndrome: Therapeutic Evaluation) registry, wherein specific parameters related to epidemiological indicators and infectious complications in patients with TEN were evaluated as a retrospective analysis. RESULTS: A total of 38 patients (97%) of the group were treated with corticosteroids. The comparison of patients with different doses of corticosteroids did not exhibit a statistically significant effect of corticosteroid administration on the development of infectious complications (p=0.421). There was no effect of the extent of the exfoliated area on the development of infectious complications in this area. The average extent of the exfoliated area was 66% TBSA (total body surface area) in patients with reported infectious complications and 71% TBSA (p=0.675) in patients without infectious complications. In the case of the development of an infectious complication in the bloodstream (BSI), the increasing effect of the SCORTEN (SCORe of Toxic Epidermal Necrosis) value was monitored during hospitalization. Within 5days from the beginning of the hospitalization, the average SCORTEN value was 2.7 in 6 patients with BSI and 3.0 in 32 patients without BSI (p=0.588). In the period after the 15th day of hospitalization, 7 patients with BSI had an average SCORTEN value of 3.4, and 16 patients without BSI had an average SCORTEN value of 2.5 (p=0.079). In the case of low respiratory tract infection (LRTI), the effects of the necessity for artificial pulmonary ventilation and the presence of tracheostomy were monitored. The statistically significant effect of mechanical ventilation on the development of LRTI occurred only during the period of 11-15days from the beginning of the hospitalization (p=0.016). The effect of the tracheostomy on the development of LRTI was proven to be more significant. CONCLUSION: We did not find any statistically significant correlation between the nature of immunosuppressive therapy and the risk of developing infectious complications. We failed to identify statistically significant risk factors for the development of BSI. Mechanical ventilation and tracheostomy increase the likelihood of developing LRTIs in patients with TEN.
Asunto(s)
Infecciones Bacterianas/epidemiología , Inmunosupresores/uso terapéutico , Micosis/epidemiología , Sistema de Registros , Síndrome de Stevens-Johnson/epidemiología , Corticoesteroides/uso terapéutico , Adulto , Anciano , Bacteriemia/epidemiología , Ciclosporina/uso terapéutico , República Checa/epidemiología , Femenino , Fungemia/epidemiología , Humanos , Inmunoglobulinas Intravenosas/uso terapéutico , Factores Inmunológicos/uso terapéutico , Masculino , Persona de Mediana Edad , Neumonía/epidemiología , Neumonía/terapia , Respiración Artificial , Estudios Retrospectivos , Factores de Riesgo , Índice de Severidad de la Enfermedad , Eslovaquia/epidemiología , Síndrome de Stevens-Johnson/terapia , Traqueostomía , Infecciones Urinarias/epidemiologíaRESUMEN
INTRODUCTION: Toxic epidermal necrolysis (TEN) is a rare, life-threatening autoimmune disease predominantly manifested in the skin and mucous membranes. Today, infectious complications have the dominant share in mortality of TEN patients. Due to the nature of the therapy and administration of immunosuppressive medications, a wide range of potentially pathogenic microorganisms, which cause infectious complications in different compartments in these patients, is not surprising. MATERIAL AND METHODOLOGY: This is a multicentric study, which included all patients with TEN hospitalized between 2000-2015 in specialized centres in the Czech Republic and Slovakia. The total catchment area was over 12.5 million inhabitants. The actual implementation of the project was carried out using data obtained from the registry CELESTE (Central European LyEll Syndrome: Therapeutic Evaluation), when specific parameters relating to epidemiological indicators and infectious complications in patients with TEN were evaluated in the form of a retrospective analysis. RESULTS: In total, 39 patients with TEN were included in the study (12 patients died, mortality was 31%), who were hospitalized in the monitored period. The median age of patients in the group was 63 years (the range was 4-83 years, the mean was 51 years), the median of the exfoliated area was 70% TBSA (total body surface area) (range 30-100%, mean 67%). SCORTEN was calculated for 38 patients on the day of admission. Its median in all patients was 3 (range 1-6; mean 3). Any kind of infectious complication in the study group was recorded in 33 patients in total (85%). In total, 30 patients (77%) were infected with gram-positive cocci, 27 patients (69%) with gram-negative rods, and yeast cells or fibrous sponge were cultivated in 12 patients (31%). A total of 32 patients (82%) were found to have infectious complications in the exfoliated area, 15 patients (39%) had lower respiratory tract infections, 18 patients (46%) urinary tract infections and 15 patients (39%) an infection in the bloodstream. The most common potentially pathogenic microorganism isolated in our study group was coagulase neg. Staphylococcus, which caused infectious complications in 24 patients. Enterococcus faecalis/faecium (19 patients), Pseudomonas aeruginosa (17 patients), Staphylococcus aureus (11 patients) and Escherichia coli (11 patients) were other most frequently isolated micro-organisms. CONCLUSION: The published data were obtained from the unique registry of TEN patients in Central Europe. In the first part, we have succeeded in defining the basic epidemiological indicators in the group of patients anonymously included in this registry. The study clearly confirms that infectious complications currently play an essential role in TEN patients, often limiting the chances of survival. The study also shows a high prevalence of these complications in the period after 15days from the start of hospitalization, when most patients already have completely regenerated skin cover.
Asunto(s)
Bacteriemia/epidemiología , Infecciones Bacterianas/epidemiología , Micosis/epidemiología , Neumonía/epidemiología , Sistema de Registros , Síndrome de Stevens-Johnson/epidemiología , Infecciones Urinarias/epidemiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Aspergilosis/epidemiología , Aspergilosis/mortalidad , Bacteriemia/microbiología , Bacteriemia/mortalidad , Infecciones Bacterianas/microbiología , Infecciones Bacterianas/mortalidad , Superficie Corporal , Candidiasis/epidemiología , Candidiasis/mortalidad , Infecciones Relacionadas con Catéteres/epidemiología , Infecciones Relacionadas con Catéteres/microbiología , Infecciones Relacionadas con Catéteres/mortalidad , Niño , Preescolar , República Checa/epidemiología , Enterococcus faecalis , Enterococcus faecium , Infecciones por Escherichia coli/epidemiología , Infecciones por Escherichia coli/mortalidad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Micosis/microbiología , Micosis/mortalidad , Neumonía/microbiología , Neumonía/mortalidad , Prevalencia , Modelos de Riesgos Proporcionales , Infecciones por Pseudomonas/epidemiología , Infecciones por Pseudomonas/microbiología , Infecciones por Pseudomonas/mortalidad , Pseudomonas aeruginosa , Eslovaquia/epidemiología , Infecciones Estafilocócicas/epidemiología , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/mortalidad , Staphylococcus aureus , Síndrome de Stevens-Johnson/microbiología , Síndrome de Stevens-Johnson/mortalidad , Infecciones Urinarias/microbiología , Infecciones Urinarias/mortalidad , Adulto JovenRESUMEN
To standardize studies on the utilization and consumption of drugs, the World Health Organization recommends the use of the Anatomical Therapeutic Chemical (ATC) classification system, using the defined daily dose (DDD value) as a technical unit of measurement of drug consumption. DDD values of total parenteral nutrition have not been established yet. In our descriptive study the methodology by E. Frankfort et al. (1993) is used. This methodology allows the calculation of both the total number of DDD values for TPN and the number of DDD values for the individual substances. Suggested DDD values and consumption of total parenteral nutrition by E. Frankfort et al. (1994) were compared with the values at the Teaching Hospital in Hradec Králové. During 3 months 142 patients administered only TPN were included in the study. The following data from every patient were collected: sex, age, the main diagnosis, composition of TPN each day and duration of this administration. The mean PDD value for carbohydrates was 200 +/- 41 g, for fat emulsion 77 +/- 27 g and for amino acids 93 +/- 16 g. The difference between our and Frankfort's results were found.